Prognostic Value of F-18-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy

Jingjing Zhang; Qingxing Liu; Aviral Singh; Christiane Schuchardt; Harshad R. Kulkarni; Richard P. Baum

doi:10.2967/jnumed.119.241414

Prognostic Value of F-18-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy

Jingjing Zhang^*, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Richard P. Baum

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1560-1569
Number of pages	10
Journal	Journal of Nuclear Medicine
Volume	61
Issue number	11
DOIs	https://doi.org/10.2967/jnumed.119.241414
Publication status	Published - 1 Nov 2020

Keywords

peptide receptor radionuclide therapy
F-18-FDG
neuroendocrine neoplasms
Lu-177
Y-90
prognostic factor
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY
GA-68-DOTATATE PET/CT
FOLLOW-UP
TUMORS
THERANOSTICS
MANAGEMENT
PREDICTS
SURVIVAL
MIDGUT
PRRT

Access to Document

10.2967/jnumed.119.241414

Cite this

@article{6d428344f65b4f2ebb37892df1abeeb5,

title = "Prognostic Value of F-18-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy",

keywords = "peptide receptor radionuclide therapy, F-18-FDG, neuroendocrine neoplasms, Lu-177, Y-90, prognostic factor, EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY, GA-68-DOTATATE PET/CT, FOLLOW-UP, TUMORS, THERANOSTICS, MANAGEMENT, PREDICTS, SURVIVAL, MIDGUT, PRRT",

author = "Jingjing Zhang and Qingxing Liu and Aviral Singh and Christiane Schuchardt and Kulkarni, {Harshad R.} and Baum, {Richard P.}",

year = "2020",

month = nov,

day = "1",

doi = "10.2967/jnumed.119.241414",

language = "English",

volume = "61",

pages = "1560--1569",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine and Molecular Imaging",

number = "11",

}

Prognostic Value of F-18-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy. / Zhang, Jingjing; Liu, Qingxing; Singh, Aviral; Schuchardt, Christiane; Kulkarni, Harshad R.; Baum, Richard P.

In: Journal of Nuclear Medicine, Vol. 61, No. 11, 01.11.2020, p. 1560-1569.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Prognostic Value of F-18-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy

AU - Zhang, Jingjing

AU - Liu, Qingxing

AU - Singh, Aviral

AU - Schuchardt, Christiane

AU - Kulkarni, Harshad R.

AU - Baum, Richard P.

PY - 2020/11/1

Y1 - 2020/11/1

KW - peptide receptor radionuclide therapy

KW - F-18-FDG

KW - neuroendocrine neoplasms

KW - Lu-177

KW - Y-90

KW - prognostic factor

KW - EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY

KW - GA-68-DOTATATE PET/CT

KW - FOLLOW-UP

KW - TUMORS

KW - THERANOSTICS

KW - MANAGEMENT

KW - PREDICTS

KW - SURVIVAL

KW - MIDGUT

KW - PRRT

U2 - 10.2967/jnumed.119.241414

DO - 10.2967/jnumed.119.241414

M3 - Article

VL - 61

SP - 1560

EP - 1569

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 11

ER -